These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12865575)

  • 21. [Kawasaki disease].
    Cimaz R; Lega JC
    Rev Prat; 2007 Nov; 57(18):1985-8. PubMed ID: 18326430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pediatric expert consensus on the application of aspirin in Kawasaki disease].
    ; ; ; ; ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):597-603. PubMed ID: 35652428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P; Ausili E; Schiavino A; Angelone DF; Focarelli B; De Rosa G; Ranno O
    Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes.
    Jaggi P; Grcic M; Kovalchin J; Wilhelm CM; Yildirim-Toruner C; Texter K
    J Pediatric Infect Dis Soc; 2018 May; 7(2):119-123. PubMed ID: 28383697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurological manifestations in atypical Kawasaki disease].
    Martínez-Guzmán E; Gámez-González LB; Rivas-Larrauri F; Sorcia-Ramírez G; Yamazaki-Nakashimada M
    Rev Alerg Mex; 2017; 64(3):376-380. PubMed ID: 29046034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the treatment of Kawasaki disease in childhood.
    Sundel RP
    Curr Rheumatol Rep; 2002 Dec; 4(6):474-82. PubMed ID: 12427361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hair loss as a sign of Kawasaki disease.
    Nabavizadeh SH; Safari M; Amin R
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):199-200. PubMed ID: 17237574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report of atypical Kawasaki disease presented with severe elevated transaminases and literature review.
    Ren Y; Zhang C; Xu X; Yin Y
    BMC Infect Dis; 2021 May; 21(1):415. PubMed ID: 33947336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience.
    Guleria S; Pilania RK; Jindal AK; Bhattarai D; Suri D; Singh S
    Int J Rheum Dis; 2019 Jul; 22(7):1183-1187. PubMed ID: 30829007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-year-old woman presenting with typical Kawasaki disease.
    Vecerek N; Dupuy EO; Kang Y; Sarantopoulos GP; Worswick S; Knowles BC
    Dermatol Online J; 2019 Jul; 25(7):. PubMed ID: 31450283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incomplete (atypical) Kawasaki disease.
    Rowley AH
    Pediatr Infect Dis J; 2002 Jun; 21(6):563-5. PubMed ID: 12182382
    [No Abstract]   [Full Text] [Related]  

  • 32. Kawasaki disease: an update on diagnosis and treatment.
    Kuo HC; Yang KD; Chang WC; Ger LP; Hsieh KS
    Pediatr Neonatol; 2012 Feb; 53(1):4-11. PubMed ID: 22348488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current state of diagnosis and treatment of incomplete Kawasaki disease].
    Zhang QY; Du JB
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):339-41. PubMed ID: 16780709
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological therapy for patients with Kawasaki disease.
    Williams RV; Minich LL; Tani LY
    Paediatr Drugs; 2001; 3(9):649-60. PubMed ID: 11688596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D; Wong M; Isaacs D
    J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kawasaki disease in adults: report of 10 cases.
    Gomard-Mennesson E; Landron C; Dauphin C; Epaulard O; Petit C; Green L; Roblot P; Lusson JR; Broussolle C; Sève P
    Medicine (Baltimore); 2010 May; 89(3):149-158. PubMed ID: 20453601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.
    ; ; ; ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):225-231. PubMed ID: 35351250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM; Giamelli J; Gewitz MH
    Cardiol Rev; 2007; 15(4):163-9. PubMed ID: 17575479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Kawasaki disease: not just for kids.
    Wolff AE; Hansen KE; Zakowski L
    J Gen Intern Med; 2007 May; 22(5):681-4. PubMed ID: 17443379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.
    Nomura Y; Arata M; Masuda K; Koriyama C; Suruki N; Ueno K; Yoshikawa H; Eguchi T; Kawano Y
    Pediatr Int; 2012 Feb; 54(1):14-8. PubMed ID: 22115193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.